Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K
Klinik und Poliklinik für Nuklearmedizin; München, Germany.
Rofo. 2002 Jun;174(6):714-20. doi: 10.1055/s-2002-32215.
Correct staging of head and neck cancer is important for the patient's prognosis and further therapeutic strategies. Aim of the present study was to investigate the diagnostic value of FDG-PET regarding the pre-surgical diagnosis of primary tumor and cervical lymph node metastases, the diagnosis of tumour recurrence, and the localisation of unknown primary, further to compare the results to those of morphological imaging modalities (CT/MRI) and to correlate the results of both methods with histopathological findings.
PATIENTS/METHODS: 115 patients (pts) (72 x primary diagnosis, 37 x recurrence, and 6 x unknown primary) underwent FDG-PET (ECAT EXACT HR+) and CT or MRI. Results were correlated with histopathological findings in terms of detection of primary and recurrent tumors as well as lymph node metastases.
Regarding the pre-surgical diagnosis, sensitivity and specificity for identifying primary tumors were 85 % and 100 % for PET and 88 % and 75 % for CT/MRI, respectively. Accuracy was 86 % for PET and 87 % for CT/MRI. Sensitivity and specificity for detecting primary lymph node involvement were 71 %/86 % for PET and 74 %/57 % for CT/MRI, resulting in an accuracy of 77 % with PET and 68 % with morphological imaging. In 23 pts histopathology revealed pT1 stages with tumor diameters < 12 mm. In 8 pts CT/MRI and in 10 pts PET failed to identify these small primary lesions. Detecting tumor recurrence (n = 37) PET showed a higher sensitivity (83 %), specificity (76 %) and accuracy (78 %) compared to CT/MRI (sensitivity: 67 %; specificity: 52 %; accuracy: 57 %). In 4/6 pts with unknown primary, imaging was able to identify a primary lesion (3/4 in FDG-PET, 2/4 in CT/MRI), in 2/6 patients even in the follow-up no primary tumor was found.
FDG-PET provides only minor additional information to morphological imaging concerning diagnosis of primary tumors. At a similar level of sensitivity, however, it seems to be more specific regarding the lymph node involvement. PET seems to be superior to CT/MRI in detecting tumor recurrence as well as occult primary tumors in pts with known cervical lymph node metastases.
对头颈部癌进行准确分期对于患者的预后及进一步的治疗策略至关重要。本研究的目的是探讨氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在原发性肿瘤和颈部淋巴结转移的术前诊断、肿瘤复发诊断及不明原发灶定位方面的诊断价值,进一步将结果与形态学成像方式(CT/MRI)的结果进行比较,并将两种方法的结果与组织病理学结果相关联。
患者/方法:115例患者(72例初次诊断、37例复发、6例不明原发灶)接受了FDG-PET(ECAT EXACT HR+)及CT或MRI检查。结果在原发性和复发性肿瘤以及淋巴结转移的检测方面与组织病理学结果相关联。
关于术前诊断,PET识别原发性肿瘤的敏感性和特异性分别为85%和100%,CT/MRI分别为88%和75%。PET的准确性为86%,CT/MRI为87%。PET检测原发性淋巴结受累的敏感性和特异性分别为71%/86%,CT/MRI为74%/57%,PET的准确性为77%,形态学成像为68%。23例患者的组织病理学显示肿瘤直径<12mm的pT1期。8例患者CT/MRI及10例患者PET未能识别这些小的原发性病变。在检测肿瘤复发(n = 37)方面,与CT/MRI相比(敏感性:67%;特异性:52%;准确性:57%),PET显示出更高的敏感性(83%)、特异性(76%)和准确性(78%)。在4/6例不明原发灶患者中,影像学能够识别原发性病变(FDG-PET为3/4,CT/MRI为2/4),2/6例患者即使在随访中也未发现原发性肿瘤。
FDG-PET在原发性肿瘤诊断方面仅为形态学成像提供少量额外信息。然而,在相似的敏感性水平下,其在淋巴结受累方面似乎更具特异性。PET在检测肿瘤复发以及已知颈部淋巴结转移患者的隐匿性原发性肿瘤方面似乎优于CT/MRI。